Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis

Journal of Neuroimmunology

Volumn 70, Issue 1, 1996, Pages 87-90

  Nicoletti, F ^a,b   Patti, F ^b   Cocuzza, C ^a   Zaccone, P ^b   Nicoletti, A ^b   Di Marco, R ^b   Reggio, A ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Autoimmune diseases; Cytokines; Experimental allergic encephalomyelitis interleukin 12; Multiple sclerosis

Indexed keywords

INTERLEUKIN 12;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0004882072     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00101-4     Document Type: Article

References (25)

1. Bendtzen, K. (1989) Immune hormones (cytokines); pathogenic role in autoimmune, rheumatic and endocrine diseases. Autoimmunity 4, 177-189.
2. Bendtzen, K. (1994) Cytokines and natural regulatur of cytokines. Immunol. Lett. 43, 111-123.
3. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D. and Rott, O. (1994) Macrophage-inactivating IL-13 suppresses experimental allergic encephalomyelitis in rats. J. Immunol., 4258-4267.
4. Frei, K., Fredrikson, S., Fontana, A. and Link, H. (1991) Interleukin-6 is elevated in plasma in multiple sclerosis. J. Neuroimmunol. 31, 147.
5. Gallo, P., Piccinno, M.G., Pagni, S., Argentiero, V., Giometto, B., Bozza, F. and Tavolato, B. (1989) Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and γ-IFN levels in serum and cerebrospinal fluid. J. Neural. Sci. 92, 91-95.
6. Hafler, D.A. and Weiner, H.L. (1995) Immunological mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144, 75-107.
7. Hunter, S.F. and Rodriguez, M. (1995) Multiple sclerosis: a unique immunopathological syndrome of the central nervous system. Springer Semin. Immunopathol. 17, 89-105.
8. Kennedy, M.K., Torrance, D.S., Picha, K.S. and Monier, K.M. (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149, 2496-2505.
9. Leonard, J.P., Waldburger, K.E. and Goldman, S.J. (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181, 381-386.
10. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38.
11. Merrill, J.E., Kono, D.H., Clayton, J., Ando, D.G., Hinton, D.R. and Hofman, F.M. (1992) Inflammatory leukocytes and cytokines in the peptide induced disease of experimental allergic encephalomyelitis in SJL/J and B10.PL mice. Proc. Natl. Acad. Sci. USA 89, 574-578.
12. Neurath, M.F., Fuss, I., Kelshall, B.L., Stuber, E. and Strober, W. (1995) Antibodies to interleukin-12 abrogates established experimental colitis in mice. J. Exp. Med. 182, 1281-1290.
13. Olsson, T., Wang, W.Z., Hojeberg, B., Kostulas, V., Jang, Y.-P., Andersson, G., Ekre, H.-P. and Link, H. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J. Clin. Invest. 86, 981-985.
14. Olsson, T. (1992) Immunology of multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 5, 195-202.
15. Peter, J.B., Boctor, F.N, and Tourtellotte, W.W. (1991) Serum and CSF levels of IL-2, sIL-2R, TNF-α, and IL-1β in chronic progressive multiple sclerosis: Expected lack of clinical utility. Neurology 141, 121-123.
16. Poser, C.M., Paty, D.W., Scheinberg, L., et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
17. Racke, M., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevac, E.M. and Rocken, M. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune diseases. J. Exp. Med. 180, 1961-1966.
18. Rieckmann, P., Albrecht, M., Kitze, B., et al. (1994) Cytokine mRNA mononuclear blood cells from MS patients with multiple sclerosis. Neurology 44, 1523-1526.
19. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W., Helwig, A. and Poser, S. (1995) Tumor necrosis factor-α messanger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37, 82-88.
20. Romagnani, S. (1994) Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12, 227-257.
21. Rott, O., Fleischer, B. and Cash, E. (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 23, 1434-1440.
22. Ruddle, N.H., Bergman, C.M., McGrath, K.M., et al. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200.
23. Selmaj, K., Raine, C.S. and Cross, A.H. (1991) Anti tumor necrosis factor factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700.
24. Trembleau, S., Germann, T., Gately, M.K. and Adorini, L. (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 8, 383-386.
25. Trinchieri, G. (1995) Interleukin-12: a pronflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.